Benitec Biopharma(BNTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BNTC Benitec Biopharma

Trading 10-02 15:12:31 EDT

9.02

-0.56

-5.90%

High9.88	Low9.02	Vol69.35K
Open9.71	D1 Closing9.58	Amplitude8.99%
Mkt Cap314.47M	Tradable Cap166.36M	Total Shares34.88M
T/O642.93K	T/O Rate0.38%	Tradable Shares18.45M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BNTC","market":"US","secType":"STK","nameCN":"Benitec Biopharma","latestPrice":9.015,"timestamp":1790968334156,"preClose":9.58,"halted":0,"volume":69347,"delay":0,"changeRate":-0.05897703549060537,"floatShares":18453400,"shares":34882700,"eps":-0.97826,"marketStatus":"Trading","change":-0.565,"latestTime":"10-02 15:12:31 EDT","open":9.71,"high":9.8761,"low":9.015,"amount":642925.1561304999,"amplitude":0.089885,"askPrice":9.04,"askSize":100,"bidPrice":8.99,"bidSize":120,"shortable":3,"etf":0,"ttmEps":-0.97826,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":2,"adr":1,"adrRate":200,"listingDate":1439870400000,"exchange":"NASDAQ","adjPreClose":9.58,"postHourTrading":{"tag":"盘后","latestPrice":9.58,"preClose":9.58,"latestTime":"19:30 EDT","volume":483,"amount":4627.14,"timestamp":1790897404380,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.636082,"impliedVol":0.4039,"impliedVolPercentile":0.2231},"requestUrl":"/m/hq/s/BNTC/","defaultTab":"news","newsList":[{"id":"2672825667","title":"Benitec Biopharma Appoints Ernst & Young as Independent Auditor for Fy2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2672825667","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672825667?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:09","pubTimestamp":1790798950,"startTime":"0","endTime":"0","summary":"Benitec Biopharma appoints Ernst & Young as independent auditor for FY2027Benitec Biopharma engaged Ernst & Young as its independent registered public accounting firm for the fiscal year ending June 3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDLb1bQF4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239323","title":"Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239323?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:30","pubTimestamp":1790591429,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on RegenXBio (RGNX), Benitec Biopharma (BNTC) and Vaxcy...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-regenxbio-rgnx-benitec-biopharma-bntc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-regenxbio-rgnx-benitec-biopharma-bntc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","BK4139","BK4585","BK4137","XBI","XLV","LABU","BNTC","BK4563","RGNX","LU0128526141.USD","BK4505","BK4581","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670241878","title":"Benitec Biopharma Switches Auditor to Ernst & Young from Baker Tilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2670241878","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670241878?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:39","pubTimestamp":1790282356,"startTime":"0","endTime":"0","summary":"Benitec Biopharma switches auditor to Ernst & Young from Baker TillyBenitec Biopharma replaced auditor Baker Tilly with Ernst & Young for the fiscal year ending June 30, 2027.Audit committee dismissed","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL531QD3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667148605","title":"BNTC: BB-301 Clinical Progress and Strong Cash Position Drive Ritu Baral’s Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2667148605","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667148605?lang=en_us&edition=fundamental","pubTime":"2026-09-16 15:25","pubTimestamp":1789543516,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Ritu Baral has maintained their bullish stance on BNTC stock, giving a Buy rating yesterday. Ritu Baral has given his Buy rating d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/bntc-bb-301-clinical-progress-and-strong-cash-position-drive-ritu-barals-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/bntc-bb-301-clinical-progress-and-strong-cash-position-drive-ritu-barals-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644720","title":"Benitec Biopharma price target raised to $17 from $16 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644720","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644720?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473619,"startTime":"0","endTime":"0","summary":"Wedbush analyst Yun Zhong raised the firm’s price target on Benitec Biopharma (BNTC) to $17 from $16 and keeps an Outperform rating on the shares. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/benitec-biopharma-price-target-raised-to-17-from-16-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/benitec-biopharma-price-target-raised-to-17-from-16-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667264114","title":"Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), CVS Health (CVS) and BioNTech SE (BNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667264114","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667264114?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:10","pubTimestamp":1789470613,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Benitec Biopharma (BNTC), CVS Health (CVS) and BioNT...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-benitec-biopharma-bntc-cvs-health-cvs-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-benitec-biopharma-bntc-cvs-health-cvs-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0162691827.USD","BK4550","LU1699723380.USD","LU1059921491.USD","IE00B19Z3581.USD","BK4548","LU0432979614.USD","LU1571399168.USD","BK4504","CVS","HCSG","IHF","LU0859254822.USD","BK4137","IE00BKVL7J92.USD","BNTC","XLV","BK4139","LU1236620750.USD","IE00B19Z3B42.SGD","LU0006061336.USD","LU0211331839.USD","LU2125909593.SGD","BK4581","XBI","RTH","LU0072461881.USD","BK4535","LU0061475181.USD","LU0128526141.USD","LU1983299246.USD","LABU","LU0070302665.USD","BNTX","BK4568","LU2433249047.HKD","IE0002270589.USD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","BK4196","BK4588","BK4585","LU2357627491.SGD","IE00BZ1G4Q59.USD","LU0208291251.USD","LU1923622614.USD","LU0320765489.SGD","LU2125909247.SGD","BK4551","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667649930","title":"Wedbush Lifts Price Target on Benitec Biopharma to $17 From $16, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2667649930","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667649930?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:48","pubTimestamp":1789469281,"startTime":"0","endTime":"0","summary":"Benitec Biopharma (BNTC) has an average rating of buy and mean price target of $24.17, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667696283","title":"Benitec Biopharma Files $200 Million Shelf Registration","url":"https://stock-news.laohu8.com/highlight/detail?id=2667696283","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667696283?lang=en_us&edition=fundamental","pubTime":"2026-09-15 05:47","pubTimestamp":1789422425,"startTime":"0","endTime":"0","summary":"Benitec Biopharma (BNTC) filed a registration statement Monday with the US Securities and Exchange Commission for the potential sale of up to $200 million in securities.The filing covers common and preferred stock, debt securities, warrants and units.Benitec shares fell 1.7% in after-hours trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667696678","title":"Benitec Biopharma files $200M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2667696678","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667696678?lang=en_us&edition=fundamental","pubTime":"2026-09-15 05:15","pubTimestamp":1789420525,"startTime":"0","endTime":"0","summary":"17:11 EDT Benitec Biopharma (BNTC) files $200M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/benitec-biopharma-files-200m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/benitec-biopharma-files-200m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667569632","title":"Benitec Biopharma - May Offer Securities up to $200 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2667569632","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667569632?lang=en_us&edition=fundamental","pubTime":"2026-09-15 05:10","pubTimestamp":1789420246,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4560KJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693062","title":"Benitec Biopharma Q4 EPS $(0.26), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693062","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693062?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:09","pubTimestamp":1789416588,"startTime":"0","endTime":"0","summary":"Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.26) per share which met the analyst consensus estimate. This is a 38.1 percent increase over losses of $(0.42) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61777182/benitec-biopharma-q4-eps-0-26-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Benitec Biopharma Q4 EPS $(0.26), Inline","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693260","title":"Benitec Biopharma Publishes Fy2026 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693260","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693260?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:00","pubTimestamp":1789416050,"startTime":"0","endTime":"0","summary":"Benitec Biopharma publishes FY2026 annual reportBenitec annual report highlighted progress for BB-301 in OPMD-related dysphagia, with Cohort 1 follow-up completed.Cohort 2 enrollment finished, with th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL1n60Zp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","BCDF","NDAQ","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BNTC","BK4585","BK4139","IE00BQXX3F31.USD","SG9999014021.USD","LU2095319765.USD","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00BN0W2W23.USD","LU0314104364.USD","LU2210149790.SGD","BK4112","BK4588","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693286","title":"Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693286","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693286?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:00","pubTimestamp":1789416000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA1JCCP2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654078270","title":"Benitec Biopharma Initiated at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2654078270","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654078270?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:59","pubTimestamp":1785243540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BNTC/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006869","title":"Benitec Biopharma Inc : Wedbush Initiates Coverage with Outperform Rating; Target Price $16","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006869","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006869?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:58","pubTimestamp":1785236331,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nFWN43U0Y6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654054080","title":"Wedbush Initiates Benitec Biopharma at Outperform With $16 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2654054080","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654054080?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:46","pubTimestamp":1785235570,"startTime":"0","endTime":"0","summary":"Benitec Biopharma (BNTC) has an average rating of buy and mean price target of $25.80, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649988265","title":"Novartis Receives European Commission Approval for Itvisma® for Spinal Muscular Atrophy (SMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649988265","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649988265?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:38","pubTimestamp":1783413535,"startTime":"0","endTime":"0","summary":"July 2 (Reuters) - NOVARTIS AG::*NOVARTIS RECEIVES EUROPEAN COMMISSION APPROVAL FOR ITVISMA FOR SPINAL MUSCULAR ATROPHY (SMA)*NOVARTIS AG - ITVISMA IS ONE-TIME FIXED DOSE GENE THERAPY FOR SMA*NOVARTIS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nRSD1xC8T6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648579485","title":"Novartis Receives European Commission Approval for Itvisma® for Spinal Muscular Atrophy (SMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648579485","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648579485?lang=en_us&edition=fundamental","pubTime":"2026-07-02 13:13","pubTimestamp":1782969201,"startTime":"0","endTime":"0","summary":"July 2 (Reuters) - NOVARTIS AG::*NOVARTIS RECEIVES EUROPEAN COMMISSION APPROVAL FOR ITVISMA FOR SPINAL MUSCULAR ATROPHY (SMA)*NOVARTIS AG - ITVISMA IS ONE-TIME FIXED DOSE GENE THERAPY FOR SMA*NOVARTIS","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nRSD1xC8T6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642428957","title":"Benitec Biopharma downgraded to Neutral from Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2642428957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642428957?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:56","pubTimestamp":1781088987,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Debjit Chattopadhyay downgraded Benitec Biopharma (BNTC) to Neutral from Buy with no price target Published first on TheFly – th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/benitec-biopharma-downgraded-to-neutral-from-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/benitec-biopharma-downgraded-to-neutral-from-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639677168","title":"Benitec Biopharma Announces Board Changes and New Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2639677168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639677168?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:39","pubTimestamp":1780087158,"startTime":"0","endTime":"0","summary":"Benitec Biopharma ( ($BNTC) ) has provided an update. On May 22, 2026, Benitec Biopharma Inc.’s board appointed David Friedman as a Class III direc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/benitec-biopharma-announces-board-changes-and-new-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/benitec-biopharma-announces-board-changes-and-new-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.benitec.com","stockEarnings":[{"period":"1week","weight":-0.0062},{"period":"1month","weight":-0.2218},{"period":"3month","weight":-0.2753},{"period":"6month","weight":-0.1227},{"period":"1year","weight":-0.3162},{"period":"ytd","weight":-0.2888}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0258},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.1429},{"period":"ytd","weight":0.1204}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.034036},{"month":2,"riseRate":0.545455,"avgChangeRate":0.090462},{"month":3,"riseRate":0.727273,"avgChangeRate":0.04636},{"month":4,"riseRate":0.454545,"avgChangeRate":0.035631},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.04959},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.105281},{"month":7,"riseRate":0.454545,"avgChangeRate":0.044486},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.000656},{"month":9,"riseRate":0.25,"avgChangeRate":-0.114389},{"month":10,"riseRate":0.583333,"avgChangeRate":-0.027767},{"month":11,"riseRate":0.272727,"avgChangeRate":-0.075117},{"month":12,"riseRate":0.545455,"avgChangeRate":-0.032403}],"exchange":"NASDAQ","name":"Benitec Biopharma","nameEN":"Benitec Biopharma","securityTypeName":"DR","adrRate":"1:200"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Benitec Biopharma(BNTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Benitec Biopharma(BNTC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Benitec Biopharma,BNTC,Benitec Biopharma股票,Benitec Biopharma股票老虎,Benitec Biopharma股票老虎国际,Benitec Biopharma行情,Benitec Biopharma股票行情,Benitec Biopharma股价,Benitec Biopharma股市,Benitec Biopharma股票价格,Benitec Biopharma股票交易,Benitec Biopharma股票购买,Benitec Biopharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Benitec Biopharma(BNTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Benitec Biopharma(BNTC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}